FS222 First in Human Study in Patients With Advanced Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
FS222 First in Human Study in Patients With Advanced Malignancies	Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasm	Recruiting	Phase 1	2025-07-01		NCT04740424

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
invoX Pharma Limited	2

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
ARENSIA Exploratory Medicine, LLC	Tbilisi	Georgia	3
Calvary Mater Newcastle	Waratah	Australia	49
Centrum Medyczne Poznan - PRATIA - PPDS	Poznan	Poland	1
Clinica Universidad Navarra	Pamplona	Spain	4
Complejo Hospitalario Universitario Insular-Materno Infantil	Las Palmas de Gran Canaria	Spain	3
Hospital Clinic de Barcelona	Barcelona	Spain	137
Hospital Clinico Universitario de Valencia	Valencia	Spain	109
Hospital Universitari Vall d'Hebron	Barcelona	Spain	200
Hospital Universitario 12 de Octubre	Madrid	Spain	359
Hospital Universitario Puerta de Hierro - Majadahonda	Majadahonda	Spain	2
Institut Catala d'Oncologia de Badalona	Barcelona	Spain	1
Instituto de Investigación Sanitaria Fundación Jimenez Díaz	Madrid	Spain	1
MCM Krakow - PRATIA - PPDS	Krakow	Poland	1
NEXT - Hospital Quironsalud Barcelona	Barcelona	Spain	1
NEXT - Hospital Universitario Quironsalud Madrid	Madrid	Spain	1
One Clinical Research Perth	Perth	Australia	1
Prof Dr I Chiricuta Institute of Oncology	Cluj-Napoca	Romania	3
Prof. Dr. Alexandru Trestioreanu Oncologic Institute	Bucharest	Romania	1
Radboud Universitair Medisch Centrum	Nijmegen	Netherlands	6
SLK Kliniken Heilbronn GmbH	Heilbronn	Germany	1
Universitary Hospital Virgen Macarena	Seville	Spain	1

Clinical trials